Why do the great majority of drug users infected with the hepatitis C virus remain untreated?
Lowenstein, W.
Annales de Medecine Interne 153(3 Suppl): 1s4-1s6
2002
ISSN/ISBN: 0003-410X PMID: 12218876 Document Number: 540934
Document emailed within 1 workday
Related Documents
Islam, A. 1992: A majority remain untreated. Bangladesh Integration 33: 46-49Liang, S.H.; Lo, Y.-C.; Lin, H.-H.; Chang, S.-Y.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Hung, C.-C.; Chang, S.-C. 2008: Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital Journal of Microbiology Immunology and Infection 41(3): 200-208
Devi, K.S.; Singh, N.B.; Singh, H.L.; Singh, Y.M. 2009: Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users Journal of the Indian Medical Association 107(3): 144; 146-147
Gyarmathy, V.A.; Rácz, J.óz. 2011: Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users Orvosi Hetilap 152(4): 124-130
Wu, N.; Li, D.; Zhu, B.; Zou, W. 2003: Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users Chinese Medical Journal 116(9): 1318-1320
Oliveira, S.A.N.; Hacker, M.A.; Oliveira, M.L.A.; Yoshida, C.F.T.; Telles, P.R.; Bastos, F.I. 2005: A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination Revista Panamericana de Salud Publica 18(4-5): 271-277
Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S. 2008: Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005 Addiction 103(10): 1687-1695
Lunel, F. 1992: Hepatitis C virus: the virus responsible of the majority of non a non B hepatitis. 2: Epidemiology of Hepatitis C Gastroenterologie Clinique et Biologique 16(6-7): 526-536
Solomon, S.S.; Celentano, D.D.; Srikrishnan, A.K.; Vasudevan, C.K.; Murugavel, K.G.; Iqbal, S.H.; Anand, S.; Kumar, M.S.; Latkin, C.; Solomon, S.; Mehta, S.H. 2010: Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India American Journal of Epidemiology 172(11): 1259-1267
Guido, M.; Rugge, M.; Colombari, R.; Cecchetto, A.; Scarpa, A.; Cadrobbi, P. 1998: Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C Italian Journal of Gastroenterology and Hepatology 30(4): 414-417
Suganuma, N.; Ikeda, S.; Taketa, K.; Wang, D.H.; Yamamoto, H.; Phornphukutkul, K.; Peerakome, S.; Sitvacharanum, K.; Jittiwutikarn, J. 1998: Risk analysis of the exposure to GB virus C/hepatitis G virus among populations of intravenous drug users, commercial sex workers and male outpatients at STD clinic in Chiang Mai, Thailand: a cross-sectional case-control study Acta Medica Okayama 52(3): 161-167
Lozano Polo, J.L.; Gutiérrez Mora, E.; Martínez Pérez, V.; Santamaría Gutiérrez, J.; Vada Sánchez, J.; Vallejo Correas, J.A. 1997: Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection Revista Clinica Espanola 197(7): 479-483
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Tun, W.; Vu, L.; Adebajo, S.B.; Abiodun, L.; Sheehy, M.; Karlyn, A.; Njab, J.; Ahonsi, B.; Issa, B.K.; Idogho, O. 2013: Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria International Journal of Std and Aids 24(8): 619-625
Verrando, R.; Robaeys, G.; Matheï, C.; Buntinx, F. 2005: Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use Acta Gastro-Enterologica Belgica 68(1): 81-85
Freeman, A.J.; Zekry, A.; Whybin, L.R.; Harvey, C.E.; van Beek, I.A.; de Kantzow, S.L.; Rawlinson, W.D.; Boughton, C.R.; Robertson, P.W.; Marinos, G.; Lloyd, A.R. 2000: Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s Medical Journal of Australia 172(12): 588-591
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Garfein, R.S.; Golub, E.T.; Greenberg, A.E.; Hagan, H.; Hanson, D.L.; Hudson, S.M.; Kapadia, F.; Latka, M.H.; Ouellet, L.J.; Purcell, D.W.; Strathdee, S.A.; Thiede, H. 2007: A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users Aids 21(14): 1923-1932
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17